NCT02035514View on ClinicalTrials.gov

Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Relapsing Remitting Multiple Sclerosis (RRMS)

Interventions

BIOLOGICAL

Bone marrow autologous mesenchymal stem cells transplantation

Trial Locations (1)

08916

Germans Trias i Pujol Hospital, Badalona

All Listed Sponsors

collaborator

Ministerio de Sanidad, Servicios Sociales e Igualdad

OTHER_GOV

lead

Germans Trias i Pujol Hospital

OTHER

NCT02035514 - Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis | Biotech Hunter | Biotech Hunter